Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Recombinant Enzyme Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110643556A details a novel recombinant E. coli strain for efficient prenol synthesis, offering superior regioselectivity and reduced manufacturing costs for global supply chains.
Patent CN111235084A reveals a cost-effective enzymatic route for S-adenosylmethionine using recombinant E. coli, offering significant supply chain advantages.
Patent CN101565685A reveals a novel recombinant E. coli strain for producing chiral acetoin and 2,3-butanediol with high ee values, offering significant cost reduction in chiral chemical manufacturing.
Patent CN104651292A reveals high-purity S-CHBE synthesis via recombinant E. coli. Achieves 100% conversion and 99.4% ee for scalable pharmaceutical intermediates.
Advanced recombinant E. coli strain for D-pantoic acid production from valine. Offers cost-effective, scalable biosynthesis for reliable vitamin B5 precursor supply chains.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.